| Primary information |
|---|
| ID | 13917 |
| Uniprot ID | P01042 |
| Description | Prolevitide [Cleaved into- Amphipathic peptide; Levitide] |
| Organism | Homo sapiens |
| Txonomy | Xenopus (subgenus); Xenopus ; Xenopodinae ; Pipidae ; Pipoidea ; Anura ; Batrachia ; Amphibia ; Tetrapoda ; Dipnotetrapodomorpha ; Sarcopterygii ; Euteleostomi ; Teleostomi ; Gnathostomata ; Vertebrata ; Craniata ; Chordata ; Deuterostomia ; Bilateria ; Eumetazoa ; Metazoa ; Opisthokonta ; Eukaryota ; cellular organisms |
| Subcellular Location | secreted |
| Developmental Stage | NA |
| Similarity | Bradykinin family |
| Tissue Specificity | Expressed by the skin glands. |
| Post Translational Modification | NA |
| Function | Influence in smooth muscle contraction;induction of hypotension;natriuresis and diuresis;decrease in blood glucose level;it is a mediator of inflammation and causes ; increase in vascular permeability;stimulation of nociceptors ; release of other mediators of inflammation ; it has a cardioprotective effect |
| Length | 88 |
| Molecular Weight | 9 |
| Name | Lysyl-bradykinin |
| Sequence | KRPPGFSPFR |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | P46663; P30411; P46663; P30411 |
| Domain | NA |
| Pharmaceutical Use | NA
|